Quantitative Sodium MRI of Prostate Cancer

Sodium (23Na) magnetic resonance imaging (MRI) has emerged as a promising molecular imaging modality to evaluate imbalances in tissue sodium concentration (TSC), a hallmark of many tumour types including prostate cancer (PCa). Changes in TSC arise from compromised cell membrane integrity and have been implicated in promoting cancer cell invasion, migration, and immune evasion. However, 23Na MRI studies of PCa are under-documented and typically performed with an endorectal coil, which introduce challenges (e.g., a non-uniform sensitivity profile, limited prostate coverage, patient discomfort) that hinder its clinical translation. In this thesis, a framework for quantitative 23Na MRI of PCa using an external 23Na transmit/receive coil at 3 Tesla is described, focusing on 23Na image sensitivity correction and TSC quantification throughout the whole prostate gland. The framework was first applied in a study of 20 participants with biopsy-proven PCa, which demonstrated significantly lower TSC in PCa lesions relative to surrounding noncancerous prostate tissue. Clinical multiparametric MRI (mpMRI) similarly measured significantly lower apparent diffusion coefficient (ADC) values, suggesting that low TSC in lesions is due in part to their high cell density. Then, to investigate whether 23Na MRI can detect PCa treatment response, 23Na MRI was performed alongside mpMRI and prostate-specific membrane antigen (PSMA)-positron emission tomography (PET) in 20 PCa participants before and after 3 months of androgen deprivation therapy. Following treatment, a significant increase in TSC, no change in ADC, and a significant decrease in PSMA uptake were observed in PCa lesions, implying a multifaceted biological response to hormone therapy. Finally, the findings of 23Na MRI, mpMRI, and PSMA-PET were validated in PCa lesions defined by whole-mount histopathology. Across 4 PCa participants, intra- and interpatient heterogeneity was observed in TSC, ADC, and PSMA uptake between lesions and normal prostate tissue, revealing the benefit of using multiple imaging modalities to detect and characterize lesions. Overall, this thesis establishes a novel, quantitative framework for external 23Na MRI of PCa, offering a non-invasive, clinically integrable approach to assess whole-prostate sodium homeostasis.

Publication Details

Journal
Scholarship@Western (Western University)
Published
2025-06-02
Primary Topic
Electrostatic Discharge in Electronics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Quantitative Sodium MRI of Prostate Cancer

Scholarship@Western (Western University)
Electrostatic Discharge in Electronics
article

Quantitative Sodium MRI of Prostate Cancer

article en

Abstract

Sodium (23Na) magnetic resonance imaging (MRI) has emerged as a promising molecular imaging modality to evaluate imbalances in tissue sodium concentration (TSC), a hallmark of many tumour types including prostate cancer (PCa). Changes in TSC arise from compromised cell membrane integrity and have been implicated in promoting cancer cell invasion, migration, and immune evasion. However, 23Na MRI studies of PCa are under-documented and typically performed with an endorectal coil, which introduce challenges (e.g., a non-uniform sensitivity profile, limited prostate coverage, patient discomfort) that hinder its clinical translation. In this thesis, a framework for quantitative 23Na MRI of PCa using an external 23Na transmit/receive coil at 3 Tesla is described, focusing on 23Na image sensitivity correction and TSC quantification throughout the whole prostate gland. The framework was first applied in a study of 20 participants with biopsy-proven PCa, which demonstrated significantly lower TSC in PCa lesions relative to surrounding noncancerous prostate tissue. Clinical multiparametric MRI (mpMRI) similarly measured significantly lower apparent diffusion coefficient (ADC) values, suggesting that low TSC in lesions is due in part to their high cell density. Then, to investigate whether 23Na MRI can detect PCa treatment response, 23Na MRI was performed alongside mpMRI and prostate-specific membrane antigen (PSMA)-positron emission tomography (PET) in 20 PCa participants before and after 3 months of androgen deprivation therapy. Following treatment, a significant increase in TSC, no change in ADC, and a significant decrease in PSMA uptake were observed in PCa lesions, implying a multifaceted biological response to hormone therapy. Finally, the findings of 23Na MRI, mpMRI, and PSMA-PET were validated in PCa lesions defined by whole-mount histopathology. Across 4 PCa participants, intra- and interpatient heterogeneity was observed in TSC, ADC, and PSMA uptake between lesions and normal prostate tissue, revealing the benefit of using multiple imaging modalities to detect and characterize lesions. Overall, this thesis establishes a novel, quantitative framework for external 23Na MRI of PCa, offering a non-invasive, clinically integrable approach to assess whole-prostate sodium homeostasis.

Scholarship@Western (Western University)
Openalex Percentile: Top 52%
Electrostatic Discharge in Electronics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Quantitative Sodium MRI of Prostate Cancer · Scholarship@Western (Western University) (2025) | TGRS Research Map | TGRS